New study tracks Real-World safety of odevixibat in rare liver disease

NCT ID NCT07585097

Recruiting now Disease control Sponsor: Ipsen Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 04, 2026 · Updated 4 times

Summary

This study will follow 30 people with Alagille syndrome who are taking odevixibat in their daily lives. The goal is to see how safe the drug is over the long term by tracking any side effects. It is not testing if the drug works, but rather monitoring its real-world safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: odevixibat
What this could lead to: If successful, this study will confirm that odevixibat is safe for long-term use in Alagille syndrome, supporting its continued use to control symptoms.
What could go wrong: This is an observational study, not a treatment trial. It only monitors safety, not effectiveness. Side effects like diarrhea may still occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alagille syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALAGILLE SYNDROME

Contacts and locations

Locations

A.O.U. Citta della Salute e della Scienza di Torino - Ospedale Infantile Regina Margherita
NOT_YET_RECRUITING

Torino, Italy
APHM - CHU Timone
NOT_YET_RECRUITING

Marseille, France
APHP - Centre Hepato-Biliaire Hospital Paul Brousse
NOT_YET_RECRUITING

Villejuif, France
APHP - Hopital Bicetre - Paris Sud
NOT_YET_RECRUITING

Le Kremlin-Bicêtre, France
APHP - Hopital Necker-Enfants Malades
NOT_YET_RECRUITING

Paris, France
Azienda Ospedaliera Di Rilievo Nazionale Santobono Pausilipon
NOT_YET_RECRUITING

Naples, Italy
Azienda Ospedaliero Universitaria Meyer
RECRUITING

Florence, Italy
CHU Dijon Bourgogne
NOT_YET_RECRUITING

Dijon, France
CHU de Montpellier - Hopital Saint Eloi
NOT_YET_RECRUITING

Montpellier, France
CHU de Toulouse - Hopital Paule de Viguier
NOT_YET_RECRUITING

Toulouse, France
Hospices Civils de Lyon - Hopital Femme Mere Enfant
NOT_YET_RECRUITING

Bron, France
IRCCS Ospedale Pediatrico Bambino Gesu
NOT_YET_RECRUITING

Roma, Italy
Ospedale Universitario Di Udine
NOT_YET_RECRUITING

Udine, Italy
University Hospital Of Padova
NOT_YET_RECRUITING

Padova, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.